ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,297.10
      -0.21%
      US Tech 100
      18,101.20
      0.12%
      Dow Jones
      39,869.38
      0.00%
      Brent Oil
      83.115
      -0.11%
      Bitcoin
      66,246.16
      1.54%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ESSA Pharma Inc (EPIX)

      7. ESSA Pharma Inc (EPIX) News

      EPIX

      ESSA Pharma (EPIX)

      ESSA Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:EPIX
      DateTimeSourceHeadlineSymbolCompany
      12:13PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology
      05/14/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
      05/14/20247:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EPIXESSA Pharma Inc
      05/14/20247:00AMPR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024NASDAQ:EPIXESSA Pharma Inc
      05/14/20247:00AMPR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024NASDAQ:EPIXESSA Pharma Inc
      05/06/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
      04/09/20248:00AMPR Newswire (Canada)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
      04/09/20248:00AMPR Newswire (US)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
      03/07/20248:13PMPR Newswire (Canada)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
      03/07/20248:13PMPR Newswire (US)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
      03/07/20245:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
      03/05/20246:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
      02/13/20247:01AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EPIXESSA Pharma Inc
      02/13/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
      02/13/20247:00AMPR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
      02/13/20247:00AMPR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
      02/07/202411:29AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
      02/06/20248:27AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
      02/06/20248:00AMPR Newswire (US)ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:EPIXESSA Pharma Inc
      02/06/20248:00AMPR Newswire (Canada)ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:EPIXESSA Pharma Inc
      01/29/20249:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
      01/26/20244:40PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EPIXESSA Pharma Inc
      01/26/20244:27PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:EPIXESSA Pharma Inc
      01/25/202410:00AMPR Newswire (Canada)ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers SymposiumNASDAQ:EPIXESSA Pharma Inc
      01/25/202410:00AMPR Newswire (US)ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers SymposiumNASDAQ:EPIXESSA Pharma Inc
      01/23/20244:09PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EPIXESSA Pharma Inc
      01/17/20248:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
      01/16/20244:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EPIXESSA Pharma Inc
      01/16/20241:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
      01/08/20248:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:EPIX